These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: R&D efficiency of leading pharmaceutical companies - A 20-year analysis.
    Author: Schuhmacher A, Wilisch L, Kuss M, Kandelbauer A, Hinder M, Gassmann O.
    Journal: Drug Discov Today; 2021 Aug; 26(8):1784-1789. PubMed ID: 34022459.
    Abstract:
    Comparative analysis of the R&D efficiency of 14 leading pharmaceutical companies for the years 1999-2018 shows that there is a close positive correlation between R&D spending and the two investigated R&D output parameters, approved NMEs and the cumulative impact factor of their publications. In other words, higher R&D investments (input) were associated with higher R&D output. Second, our analyses indicate that there are 'economies of scale' (size) in pharmaceutical R&D.
    [Abstract] [Full Text] [Related] [New Search]